Weight Loss Drug Copycat Makers Seek Court Shield From FDA

Drug compounders making copycat versions of Eli Lilly & Co.’s tirzepatide are urging a federal judge to shield them from FDA enforcement while a court decides whether the agency lawfully stopped listing the weight loss drug as in shortage.

The Outsourcing Facilities Association and FarmaKeio Custom Compounding filed a motion for preliminary injunction Tuesday in the US District Court for the Northern District of Texas that would prohibit the Food and Drug Administration from taking any action against them while they compound tirzepatide.

The request comes in an ongoing legal battle over whether the FDA lawfully determined in October ...